Stock Market Reviews

XFOR (X4 Pharmaceuticals, Inc.) News

Get the latest news, insights, and market updates on XFOR (X4 Pharmaceuticals, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
  BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock and pre-funded warrants to purchase 48,852,772 shares of common stock for total offering proceeds of $85 million. The originally announced offering of $60 million was increased to allow for the inclusion of an investor who had a pre-existing investment ri
  Aug 13, 2025 - $XFOR
• X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership
  $60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise Associates Newly appointed board and management team includes Dr. Adam Craig as Executive Chairman, John Volpone as President and David Kirske as Chief Financial Officer BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it has entered into a securities purchase a
  Aug 12, 2025 - $XFOR
• X4 Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
  NasdaqCM:XFOR 1 Year Share Price vs Fair Value Explore X4 Pharmaceuticals's Fair Values from the Community and select...
  Aug 11, 2025 - $XFOR
• X4 Pharmaceuticals: Q2 Earnings Snapshot
  BOSTON (AP) — X4 Pharmaceuticals, Inc. XFOR) on Friday reported a loss of $25.7 million in its second quarter. On a per-share basis, the Boston-based company said it had a loss of $3.47.
  Aug 8, 2025 - $XFOR